6:16 PM
 | 
Dec 19, 2011
 |  BC Extra  |  Company News

Janssen, Metamark in cancer deal

Janssen Biotech Inc. partnered with Metamark Genetics Inc. (Cambridge, Mass.) to identify cancer targets using Metamark's Prognosis Determinant discovery technology. The Johnson &...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >